CN102228554A - Medicament for treating empyrosis and scalding and preparation method thereof - Google Patents
Medicament for treating empyrosis and scalding and preparation method thereof Download PDFInfo
- Publication number
- CN102228554A CN102228554A CN2011101839227A CN201110183922A CN102228554A CN 102228554 A CN102228554 A CN 102228554A CN 2011101839227 A CN2011101839227 A CN 2011101839227A CN 201110183922 A CN201110183922 A CN 201110183922A CN 102228554 A CN102228554 A CN 102228554A
- Authority
- CN
- China
- Prior art keywords
- percent
- medicament
- cera flava
- medicine
- heating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- 238000010438 heat treatment Methods 0.000 claims abstract description 14
- 239000007766 cera flava Substances 0.000 claims description 39
- 241000283956 Manis Species 0.000 claims description 23
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 abstract description 16
- 230000036407 pain Effects 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 210000003780 hair follicle Anatomy 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 239000003292 glue Substances 0.000 abstract 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 2
- 244000060924 Brassica campestris Species 0.000 abstract 2
- 235000006008 Brassica napus var napus Nutrition 0.000 abstract 2
- 241000099774 Cuscuta salina Species 0.000 abstract 2
- 241000972672 Phellodendron Species 0.000 abstract 2
- 241000283966 Pholidota <mammal> Species 0.000 abstract 2
- 229940116229 borneol Drugs 0.000 abstract 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 239000008159 sesame oil Substances 0.000 abstract 2
- 235000011803 sesame oil Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 19
- 239000006071 cream Substances 0.000 description 10
- 206010053615 Thermal burn Diseases 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 8
- 230000000699 topical effect Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a medicament for treating empyrosis and scalding and a preparation method thereof. The medicament of a formula comprises the following components in percentage by weight: 25 to 40 percent of bee glue, 2 to 5 percent of golden thread, 1 to 3 percent of phellodendron, 1 to 3 percent of pangolin scales, 1 to 2 percent of borneol, 30 to 55 percent of colza oil and 15 to 32 percent of sesame oil. The preparation method comprises the following steps of: grinding the golden thread, the phellodendron, the pangolin scales and the borneol into 80 to 100-mesh powder for later use; putting the colza oil and the sesame oil into a container, and heating to the temperature of between 180 and 240 DEG C; adding the bee glue, and after the bee glue is dissolved completely, cooling naturally to the temperature of between 60 and 80 DEG C; and adding the powdery medicaments ground in advance, heating, stirring and decocting at the heating temperature of between 60 and 80 DEG C for 200 to 240 minutes, and concentrating to form paste. The medicament can produce an effect quickly in inflammation diminishing and detumescence and has an obvious effect of easing pain, and a physiological structure of skin hair follicles can be reconstructed. By the preparation method, active ingredients of each medicament can be kept effectively, so that the prepared medicament is high in curative effect.
Description
Technical field
The technical field of pharmaceuticals that the invention belongs to the treatment burn and scald.
Background technology
Existing treatment burn and the medicine of scalding, have that medical expense is high, patient's pain obviously, many, the anti-inflammation detumescence of injury transudate slowly, can't rebuild the skin follicle physiological structure, treatment time is grown even need the surgery cost of great number to carry out characteristics such as skin grafting, and leave a large amount of cicatrixes after healing usually, patient's appearance changes bigger, the limb function serious degradation, be subjected to society, family's grievous discrimination, mental pressure is huge.
Summary of the invention
Purpose of the present invention provides a kind of anti-inflammation detumescence instant effect just for the weak point that overcomes the existing medicine for the treatment of burn and scalding, analgesic effect is remarkable and can rebuild the treatment burn of skin follicle physiological structure and the cream drug of scald, and the present invention also provides the preparation method of this medicine.
The objective of the invention is to realize by following technical solution.
A kind of medicine for the treatment of empyrosis, the weight ratio of this pharmaceutical formulation is: Cera Flava 25%-40%, Rhizoma Coptidis 2%-5%, Cortex Phellodendri 1%-3%, Squama Manis 1%-3%, Borneolum Syntheticum 1%-2%, Oleum Brassicae campestris 30%-55%, Oleum sesami 15%-32%.
A kind of preparation method for the treatment of the medicine of empyrosis, be milled into behind the 80-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 180 ℃-240 ℃ of degree, put into Cera Flava then, treat that Cera Flava dissolves fully after, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat is under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 200-240 minute and to boil, be condensed into behind the paste.Advance the remarkable efficacy of skin follicle functional rehabilitation.Damage the property injury owing to the cause of disease of burn and scald mostly is skin, the muscle that the reason of physics or chemistry causes, medicine of the present invention is used for the treatment of burn and scald and has significant curative effect.Have the treatment II ° with interior burn, skin healing is good, preventing from scar; III is ° with interior burn, and cicatrix is light, does not influence limb function, and can rebuild the advantages such as physiological structure of skin, hair follicle. and on Chinese medicine and pharmacy, Cera Flava just has the effect of detoxifcation, granulation promoting, analgesic therapy from ancient times.Through the discovering of western medicine in modern age, effect such as Cera Flava has that antiinflammatory is antibacterial, local anesthesia, blood fat reducing and prevention of arterial are atherosis.When being applied to burn wound's treatment, Cera Flava is the base substance that forms framework.Cera Flava is to be secreted out by the abdominal part of Apis, is the material of Apis nesting, and main component is the palmitic acid cerolein, molecular formula is C15H31COOC30H61, and fusing point is 62～67 ℃, can increase the denseness of ointment, and more weak water absorption is arranged, and the suction back forms thick water-in-oil type (W/O) Emulsion.Because the Cera Flava molecular weight is bigger, fusing point is higher, and easily forms network, so played the effect of framework, each space during this framework cuts off is 19～25 millimicrons.The oil droplet that contains the mass efficient composition can freely pass through in framework, is easily absorbed by wound surface, degrades, and comprising: hydrolysis, enzymolysis, become sour and saponification.Cera Flava has then been stayed the outside of wound surface, and framework and water miscible material have formed white protecting film.Rhizoma Coptidis bitter in the mouth cold in nature has heat clearing and damp drying, the effect of eliminating fire and detoxication.The Cortex Phellodendri heat clearing and damp drying, eliminating fire and detoxication, clearind deficient heat can be used for pathopyretic ulcer, diseases such as eczema.Squama Manis has the eliminating carbuncle evacuation of pus, external hemostatic effect.Borneolum Syntheticum has antiinflammatory, antibiotic, the effect of clearing away heat to alleviate pain.Oleum sesami has moist, the effect of removing the necrotic tissue and promoting granulation.
Medicine of the present invention has that detoxicating is analgesic, antibiotic, the pain relieving of sterilization, change corruption, granulation promoting, short with interior burn, and cicatrix is light, does not influence limb function, and can rebuild the physiological structure of skin follicle.
Process for preparing medicine of the present invention can effectively keep the effective ingredient of each medicine, makes the curative effect of medication for preparing best.And preparation method is simple.
Aspect treatment time, for I ° burn and scald, the drug of topical application obviously took effect later in 1 hour, showed as that pain disappears, redness obviously alleviates, and cured in 3-5 days.For II ° burn and scald, the drug of topical application obviously took effect later in 3 days, showed as 1 hour later pain relief of the drug of topical application, and 3 days later rednesses of the drug of topical application alleviate, and cure in 7-20 days.For depth-III ° burn and scald, the drug of topical application obviously took effect later in 7 days, show as the drug of topical application 1 day after pain obviously alleviate, redness obviously alleviates after 7 days, the wound sepage obviously reduces in the drug of topical application, cures in 50-70 days.
This product external is applicable to various burns, scald, innominate toxic swelling, external hemorrhoid etc.
Cream drug of the present invention uses through the surgery and the 20000 many cases patients among the people of how tame medical institutions, and to burn, scald, innominate toxic swelling, external hemorrhoid etc., the external application affected part had significant curative effect after 1-24 hours; According to course of therapy, total effective rate reaches more than 98%.
Further set forth content of the present invention below in conjunction with embodiment.
The specific embodiment
Embodiment one
The weight ratio of pharmaceutical formulation is: Cera Flava 25%, Rhizoma Coptidis 3%, Cortex Phellodendri 3%, Squama Manis 3%, Borneolum Syntheticum 1%, Oleum Brassicae campestris 45%, Oleum sesami 20%.Be milled into behind the 80 purpose powderies Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 180 ℃-200 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, after boiling, be condensed into paste, stirring in 200 minutes promptly obtains medicine of the present invention.
Embodiment two
The weight ratio of pharmaceutical formulation is: Cera Flava 29%, Rhizoma Coptidis 5%, Cortex Phellodendri 1%, Squama Manis 1%, Borneolum Syntheticum 2%, Oleum Brassicae campestris 30%, Oleum sesami 32%.Be milled into behind the 100 purpose powderies Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 200 ℃-220 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 220 minutes and to boil, be condensed into behind the paste cream drug.
Embodiment three
The weight ratio of pharmaceutical formulation is: Cera Flava 40%, Rhizoma Coptidis 2%, Cortex Phellodendri 2%, Squama Manis 2%, Borneolum Syntheticum 2%, Oleum Brassicae campestris 37%, Oleum sesami 15%.Be milled into behind the 80 purpose powderies Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 220 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-70 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-70 ℃ of degree, stirred through 240 minutes and to boil, be condensed into behind the paste cream drug.
Embodiment four
The weight ratio of pharmaceutical formulation is: Cera Flava 25%, Rhizoma Coptidis 2%, Cortex Phellodendri 1%, Squama Manis 1%, Borneolum Syntheticum 1%, Oleum Brassicae campestris 55%, Oleum sesami 15%.Be milled into behind the 80-90 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 200 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 70 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 70 ℃ of-80 ℃ of degree, stirred through 200-220 minute and to boil, be condensed into behind the paste cream drug.
Embodiment five
The weight ratio of pharmaceutical formulation is: Cera Flava 40%, Rhizoma Coptidis 2%, Cortex Phellodendri 2%, Squama Manis 2%, Borneolum Syntheticum 2%, Oleum Brassicae campestris 37%, Oleum sesami 15%.Be milled into behind the 90-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 180 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 220-240 minute and to boil, be condensed into behind the paste cream drug.
Embodiment six
The weight ratio of pharmaceutical formulation is: Cera Flava 50g, Rhizoma Coptidis 8g, Cortex Phellodendri 2g, Squama Manis 6g, Borneolum Syntheticum 2g, Oleum Brassicae campestris 68g, Oleum sesami 64g.Be milled into behind the 90 purpose powderies Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 210 ℃-230 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 220-230 minute and to boil, be condensed into behind the paste cream drug.
Embodiment seven
The weight ratio of pharmaceutical formulation is: Cera Flava 120g, Rhizoma Coptidis 6g, Cortex Phellodendri 6g, Squama Manis 3g, Borneolum Syntheticum 6g, Oleum Brassicae campestris 90g, Oleum sesami 69g.Be milled into behind the 90-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 220 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-70 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-70 ℃ of degree, stirred through 230-240 minute and to boil, be condensed into behind the paste cream drug.
Embodiment eight
The weight ratio of pharmaceutical formulation is: Cera Flava 70g, Rhizoma Coptidis 10g, Cortex Phellodendri 6g, Squama Manis 4g, Borneolum Syntheticum 3g, Oleum Brassicae campestris 77g, Oleum sesami 30g.Be milled into behind the 80-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 200 ℃-220 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 70 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 70 ℃ of-80 ℃ of degree, stirred through 200-220 minute and to boil, be condensed into behind the paste cream drug.
Embodiment nine
The weight ratio of pharmaceutical formulation is: Cera Flava 75g, Rhizoma Coptidis 6g, Cortex Phellodendri 3g, Squama Manis 3g, Borneolum Syntheticum 3g, Oleum Brassicae campestris 165g, Oleum sesami 45g.Be milled into behind the 80-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 200 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 200-240 minute and to boil, be condensed into behind the paste cream drug.
Claims (2)
1. a medicine for the treatment of empyrosis is characterized in that, the weight ratio of this pharmaceutical formulation is: Cera Flava 25%-40%, Rhizoma Coptidis 2%-5%, Cortex Phellodendri 1%-3%, Squama Manis 1%-3%, Borneolum Syntheticum 1%-2%, Oleum Brassicae campestris 30%-55%, Oleum sesami 15%-32%.
2. a kind of preparation method for the treatment of the medicine of empyrosis as claimed in claim 1, it is characterized in that, be milled into behind the 80-100 purpose powdery Rhizoma Coptidis, Cortex Phellodendri, Squama Manis, Borneolum Syntheticum standby, earlier Oleum Brassicae campestris and Oleum sesami are put into container internal heating to 180 ℃-240 ℃ of degree, put into Cera Flava then, after treating that Cera Flava dissolves fully, naturally cool to 60 ℃ of-80 ℃ of degree again, add the medicine that grinds to form powdery in advance then, reheat, under the heating-up temperature condition of keeping 60 ℃ of-80 ℃ of degree, stirred through 200-240 minute and to boil, be condensed into behind the paste.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101839227A CN102228554B (en) | 2011-07-02 | 2011-07-02 | Medicament for treating empyrosis and scalding and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101839227A CN102228554B (en) | 2011-07-02 | 2011-07-02 | Medicament for treating empyrosis and scalding and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228554A true CN102228554A (en) | 2011-11-02 |
| CN102228554B CN102228554B (en) | 2013-04-10 |
Family
ID=44841186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101839227A Expired - Fee Related CN102228554B (en) | 2011-07-02 | 2011-07-02 | Medicament for treating empyrosis and scalding and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228554B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526438A (en) * | 2012-02-24 | 2012-07-04 | 阳俊才 | Drug for treating burn and scald and preparation method of same |
| CN104257718A (en) * | 2014-10-13 | 2015-01-07 | 王亚斌 | Medicine for treating burns |
| CN112807354A (en) * | 2021-04-09 | 2021-05-18 | 陈国平 | Scald and burn ointment and preparation method thereof |
| CN114010738A (en) * | 2021-12-07 | 2022-02-08 | 崔献德 | Skin disease treatment formula |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096203A (en) * | 1993-06-10 | 1994-12-14 | 王大刚 | Chinese medicine burn cream and method for making thereof |
-
2011
- 2011-07-02 CN CN2011101839227A patent/CN102228554B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096203A (en) * | 1993-06-10 | 1994-12-14 | 王大刚 | Chinese medicine burn cream and method for making thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526438A (en) * | 2012-02-24 | 2012-07-04 | 阳俊才 | Drug for treating burn and scald and preparation method of same |
| CN102526438B (en) * | 2012-02-24 | 2013-10-30 | 阳俊才 | Drug for treating burn and scald and preparation method of same |
| CN104257718A (en) * | 2014-10-13 | 2015-01-07 | 王亚斌 | Medicine for treating burns |
| CN112807354A (en) * | 2021-04-09 | 2021-05-18 | 陈国平 | Scald and burn ointment and preparation method thereof |
| CN114010738A (en) * | 2021-12-07 | 2022-02-08 | 崔献德 | Skin disease treatment formula |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228554B (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3466447A1 (en) | Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
| AU2014212561A1 (en) | Compositions and methods for treating surface wounds | |
| CN104288504B (en) | A kind of Chinese medicine ointment formulation for treating burn, scald and preparation method thereof | |
| CN102228554B (en) | Medicament for treating empyrosis and scalding and preparation method thereof | |
| CN105030620A (en) | Moisturizing and acne removing facial cleanser and preparing method thereof | |
| CN101711807B (en) | Antiphlogistic and antibiotic ointment | |
| CN104906466B (en) | A kind of folium eucalypti emulsifiable paste and preparation method thereof | |
| KR101674163B1 (en) | Moxa composition and producing method thereof | |
| CN106822321B (en) | Application of Curcuma water of traumatology in preparing medicine for treating keratosis pilaris | |
| CN103768388A (en) | Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally | |
| KR101374537B1 (en) | Pharmaceutical Composition for Burn Treatment Using Gombo-Baechu | |
| US9421235B2 (en) | Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient | |
| WO2018161890A1 (en) | Application of berberine in preparing drug for treating acute soft tissue injury | |
| CN1385193A (en) | Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration | |
| CN113197973A (en) | Pharmaceutical composition and preparation method thereof | |
| CN1217683C (en) | Prescription of lotion for treating pile and fistula and its preapring process | |
| CN111991471A (en) | A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method | |
| CN105233271A (en) | Anti-scaring andrias skin collagen burn cream and preparation method thereof | |
| CN105288455A (en) | Medicine for treating scalds and burns | |
| CN111773341A (en) | Compound Chinese herbal medicine external preparation for treating piglet mange | |
| CN107050298B (en) | Preparation method of traditional Chinese medicine ointment for treating skin injuries caused by burns and scalds | |
| CN100355437C (en) | Medicine for treating scald and burn and preparing method | |
| CN109223931A (en) | A kind of burn cream and preparation method thereof for treating burn | |
| CN105288456A (en) | Preparation method of medicine for treating scalds and burns | |
| CN102000219B (en) | Medicament for treating burns and scalds as well as preparation and use method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |